Search results for "Continuous"

showing 10 items of 899 documents

New rules on driver licensing for patients with obstructive sleep apnoea: EU Directive 2014/85/EU.

2016

The widespread recognition that obstructive sleep apnoea (OSA) represents an important risk factor for motor vehicle accidents (MVA), which is reversed by successful therapy with continuous positive airway pressure (CPAP), has led to a revision of annex III of the European Union (EU) directive on driving licences that is subject to mandatory implementation by all member states from December 31, 2015 [1]. This directive was the result of recommendations from a working group established by the Transport and Mobility Directorate of the European Commission in 2012 [2]. The directive states [1] Joint ERS/ESRS working group on the EU directive on issuing driving licences in obstructive sleep apno…

Pulmonary and Respiratory MedicineAutomobile Drivingmedicine.medical_treatmentsleepinessSeverity of Illness Index03 medical and health sciences0302 clinical medicinemedia_common.cataloged_instanceMedicineHumansEuropean commissionOperations managementContinuous positive airway pressureEuropean UnionEuropean unionmedia_commonLicensureSleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industryMember statesAccidents TrafficDriver licensingDirectiverespiratory tract diseases030228 respiratory systemSleep (system call)businessLicensure030217 neurology & neurosurgery
researchProduct

Documento de consenso del síndrome de apneas-hipopneas durante el sueño en niños (versión completa)

2011

Pulmonary and Respiratory MedicineGynecologymedicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentmedicinePolysomnographyContinuous positive airway pressurebusinessArchivos de Bronconeumología
researchProduct

Effectiveness and safety of a new helmet CPAP configuration allowing tidal volume monitoring in patients with COVID-19.

2021

Abstract Background High generated tidal volumes (Vt) have been correlated with higher risk of self-induced lung injury and worse clinical outcome. This study aimed to evaluate the effectiveness and safety of a new helmet continuous positive airway pressure delivered (h-CPAP) configuration allowing Vt monitoring in patients affected by COVID-19. Methods This prospective observational study was performed in the respiratory intermediate care unit of University Hospital in Turin, Italy, between March 24th, and June 15th, 2020. Included patients were treated with CPAP via a single-limb intentional leak configuration by a turbine-driven ventilator, provided with a dedicated patch. Effectiveness …

Pulmonary and Respiratory MedicineLeakTidal volume monitoringmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)List of abbreviations: ARF Acute respiratory failuremedicine.medical_treatmentLung injuryTidal volumeVt Tidal volumeCPAPMedicineIn patientContinuous positive airway pressureTidal volumeHelmetCPAP Continuous positive airway pressureRICU Respiratory intermediate care unitbusiness.industryCOVID-19ICU Intensive care unitEmergency medicineHFNT High flow nasal therapyObservational studyOriginal ArticleTDVs turbine-driven ventilatorsbusinessPulmonology
researchProduct

Obstructive sleep apnoea in acute coronary syndrome.

2019

Obstructive sleep apnoea (OSA) syndrome affects about 13% of the male and 7–9% of the female population. Hypoxia, oxidative stress and systemic inflammation link OSA and cardiovascular and metabolic consequences, including coronary artery disease. Current research has identified several clinical phenotypes, and the combination of breathing disturbances during sleep, systemic effects and end-organ damage might help to develop personalised therapeutic approaches. It is unclear whether OSA is a risk factor for acute coronary syndrome (ACS) and might affect its outcome. On the one hand, OSA in patients with ACS may worsen prognosis; on the other hand, OSA-related hypoxaemia could favour the dev…

Pulmonary and Respiratory MedicineMaleAcute coronary syndromemedicine.medical_specialtymedicine.medical_treatmentSettore MED/10 - Malattie Dell'Apparato Respiratorio030204 cardiovascular system & hematologySystemic inflammationCoronary artery disease03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinePositive airway pressurePrevalenceMedicineHumansContinuous positive airway pressureNon disponibiliAcute Coronary SyndromeAdverse effectLunglcsh:RC705-779Sleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industryRespirationHemodynamicsSleep apnealcsh:Diseases of the respiratory systemHypoxia (medical)medicine.diseasenervous system diseasesrespiratory tract diseasesTreatment Outcome030228 respiratory systemCardiologyPatient ComplianceFemalemedicine.symptombusinessSleepEuropean respiratory review : an official journal of the European Respiratory Society
researchProduct

Tolerance of Volume Control Noninvasive Ventilation in Subjects With Amyotrophic Lateral Sclerosis.

2015

BACKGROUND: Noninvasive ventilation (NIV) tolerance has been identified as an independent predictor of survival in amyotrophic lateral sclerosis (ALS). Volume control continuous mandatory ventilation (VC-CMV) NIV has been associated with poor tolerance. The aim of this study was to determine the tolerance of subjects with ALS to VC-CMV NIV. METHODS: This was a prospective study involving subjects with ALS who were treated with VC-CMV NIV. Respiratory and functional parameters were recorded when the subjects began ventilatory support. NIV tolerance was evaluated after 3 months. RESULTS: Eighty-seven subjects with ALS were included. After 3 months, 80 subjects (92%) remained tolerant of NIV. …

Pulmonary and Respiratory MedicineMaleNeuromuscular diseaseTime FactorsPeak Expiratory Flow RateCritical Care and Intensive Care MedicineVolume controlContinuous mandatory ventilationForced Expiratory VolumemedicineHumansProspective StudiesRespiratory systemAmyotrophic lateral sclerosisProspective cohort studyAgedNoninvasive Ventilationbusiness.industryAmyotrophic Lateral SclerosisGeneral MedicineMiddle Agedmedicine.diseaseRespiratory failureCoughAnesthesiaNoninvasive ventilationFemalebusinessRespiratory InsufficiencyRespiratory care
researchProduct

A Bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnoea: a multicentre randomised controlled trial

2015

Background Compliance with continuous positive airway pressure (CPAP) therapy is essential in patients with obstructive sleep apnoea (OSA), but adequate control is not always possible. This is clinically important because CPAP can reverse the morbidity and mortality associated with OSA. Telemedicine, with support provided via a web platform and video conferences, could represent a cost-effective alternative to standard care management. Aim To assess the telemedicine impact on treatment compliance, cost-effectiveness and improvement in quality of life (QoL) when compared with traditional face-to-face follow-up. Methods A randomised controlled trial was performed to compare a telemedicine-bas…

Pulmonary and Respiratory MedicineMaleTelemedicinemedicine.medical_specialtyEpidemiologymedicine.medical_treatmentCost-Benefit Analysislaw.inventionIndirect costsClinical trialsQuality of lifeRandomized controlled triallawmedicineHumansContinuous positive airway pressureProspective StudiesDisease management (health)EpidemiologiaTelecommunication in medicineSleep apnea syndromesPrimary health careSleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industryDisease ManagementBayes TheoremCost-effectiveness analysisSíndromes d'apnea del sonMiddle AgedTelemedicinenervous system diseasesrespiratory tract diseasesClinical trialAtenció primàriaPhysical therapyQuality of LifePatient ComplianceFemalebusinessSleepFollow-Up StudiesTelecomunicació en medicinaAssaigs clínics
researchProduct

Sleep apnoea management in Europe during the COVID-19 pandemic: data from the European Sleep Apnoea Database (ESADA)

2020

Sleep disordered breathing (SDB) is highly prevalent with a male to female predominance of two to one, and is more common in middle-aged and elderly subjects [1]. Affected patients often present with comorbidities such as obesity, cardiovascular disease (systemic hypertension, heart failure, atrial fibrillation), and diabetes mellitus Type II [2]. The strong overlap between the profile for SDB patients and the identified risk factors for adverse outcomes of COVID-19 infection that include age, male gender, and cardio-metabolic comorbidity [3] suggest that SDB patients may benefit from effective therapy if confronted with COVID-19 infection [4].

Pulmonary and Respiratory MedicinePediatricsmedicine.medical_specialtyDatabases FactualPolysomnographymedicine.medical_treatmentPneumonia ViralPersonnel Staffing and SchedulingPolysomnographyDiseaseCovidsleep laboratoryBetacoronavirus03 medical and health sciencesSleep Apnea SyndromeSleep Apnea Syndromes0302 clinical medicineSurveys and Questionnairesmental disordersResearch LettermedicineHumanscardiovascular diseases030212 general & internal medicineContinuous positive airway pressurePandemicsSleep Medicine SpecialtyContinuous Positive Airway Pressuremedicine.diagnostic_testCoronavirus InfectionSARS-CoV-2business.industrySleep apneaCOVID-19Atrial fibrillationmedicine.diseaseComorbidityObesityTelemedicineEuropeSleep Medicine Specialty030228 respiratory systemHeart failureCoronavirus InfectionsbusinessDelivery of Health CaremanagementEuropean Respiratory Journal
researchProduct

Mild obstructive sleep apnoea: clinical relevance and approaches to management

2015

Summary Obstructive sleep apnoea is highly prevalent in the general population worldwide, especially in its mild form. Clinical manifestations correlate poorly with disease severity measured by the apnoea–hypopnoea index (AHI), which complicates diagnosis. Full polysomnography might be more appropriate to assess suspected mild cases because limited ambulatory diagnostic systems are least accurate in mild disease. Treatment options in mild obstructive sleep apnoea include continuous positive airway pressure (CPAP) and oral appliance therapy, in addition to positional therapy and weight reduction when appropriate. The superior efficacy of CPAP in reducing AHI is offset by greater tolerance of…

Pulmonary and Respiratory MedicineRespiratory Therapymedicine.medical_specialtymedicine.medical_treatmentOral appliancePopulationPolysomnographySettore MED/10 - Malattie Dell'Apparato RespiratorioPatient Positioning03 medical and health sciences0302 clinical medicinestomatognathic systemmedicineHumansClinical significanceContinuous positive airway pressureDisease management (health)Intensive care medicineeducationSleep Apnea Obstructiveeducation.field_of_studyContinuous Positive Airway Pressuremedicine.diagnostic_testbusiness.industryDisease ManagementSleep apneamedicine.diseasenervous system diseasesrespiratory tract diseases030228 respiratory systemAmbulatoryPhysical therapybusiness030217 neurology & neurosurgery
researchProduct

Material and Technology: Back to the Future for the Choice of Interface for Non-Invasive Ventilation – A Concise Review

2020

Non-invasive ventilation (NIV) has dramatically changed the treatment of both acute and chronic respiratory failure in the last 2 decades. The success of NIV is correlated to the application of the “best ingredients” of a patient’s “tailored recipe,” including the appropriate choice of the selected candidate, the ventilator setting, the interface, the expertise of the team, and the education of the caregiver. The choice of the interface is crucial for the success of NIV. Type (oral, nasal, nasal pillows, oronasal, hybrid mask, helmet), size, design, material and headgears may affect the patient’s comfort with respect to many aspects, such as air leaks, claustrophobia, skin erythema, eye irr…

Pulmonary and Respiratory MedicineRespiratory failure.medicine.medical_specialtySkin erythemamedicine.medical_treatmentInterface (computing)Skin breakdownlaw.invention03 medical and health sciencesFacial deformity0302 clinical medicinelawHumansMedicine030212 general & internal medicineIntensive care medicineReduction (orthopedic surgery)Noninvasive VentilationContinuous Positive Airway Pressurebusiness.industryMasksEquipment DesignHome ventilationInterfacemedicine.diseaseHome setting030228 respiratory systemVentilation (architecture)Non-invasive ventilationClaustrophobiaRespiratory Insufficiencybusiness
researchProduct

Decrease in blood pressure during continuous positive airway pressure treatment for obstructive sleep apnoea: still searching for predictive factors

2019

High blood pressure (BP) and non-dipping 24-hour BP profile may help to predict BP decrease after obstructive sleep apnoea treatment by CPAP. However, specific, highly reproducible traits associated with BP responsiveness to CPAP must still be identified.http://bit.ly/2LbS4uV

Pulmonary and Respiratory Medicinearterial hypertensionmedicine.medical_specialtymedicine.medical_treatmentBlood PressureSettore MED/10 - Malattie Dell'Apparato Respiratorioblood pressure dipping03 medical and health sciences0302 clinical medicineText miningCPAPInternal medicinemedicineHumans030212 general & internal medicineContinuous positive airway pressureobstructive sleep apneatherapySleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industryBlood Pressure DeterminationSleep in non-human animalsnervous system diseasesrespiratory tract diseasesBlood pressure030228 respiratory systemHypertensionCardiologybusinessHuman
researchProduct